Anti-citrullinated protein antibodies (ACPA) are a key biomarker in rheumatoid arthritis (RA), but a recent study has suggested that ACPA studies may not fully identify the biological distinctions ...
NANTES, France, 22 April 2025 – In a wide-ranging Genomic Press Interview, Dr. Jeremie Poschmann of INSERM and Université de Nantes shares the story behind his bold, data-centric approach to ...
Incidence and survival trends in early-onset colorectal cancer. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I. This abstract does not include a full text component.
We compared the TuPro melanoma cohort (n = 98), which received multi-omics–guided selection of adjuvant, standard of care and beyond standard-of-care therapies in patients with advanced melanoma, to a ...
Recent advances in single-cell sequencing and spatial multi-omics have transformed our ability to resolve tumor ecosystems at unprecedented resolution.
The rapid evolution of high-throughput sequencing and mass spectrometry has positioned clinical multi-omics at the forefront of modern laboratory medicine. By analyzing multiple biological layers ...
Graph Therapeutics is a biotech company developing precision medicines for inflammatory and immune-mediated diseases using AI ...
A study led by researchers at Stanford Medicine has shown that differences in blood sugar responses to certain carbohydrates depend on details of an individual’s metabolic health status, including ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results